Professor Dr. Stoecker writes: "...The Lübeck vaccine uses a tailored, small and trivial genetically engineered antigen that the body does not need to synthesise itself as is the case with nucleic acid-based methods. In the organism of the recipient, it induces the production of antibodies against the Spike protein of SARS-Cov2 that the virus uses to bind to the angiotensin-2 receptors on endothelial cells, alveolar cells and enterocytes in unvaccinated individuals. By this blocking, the antibodies prevent infection of the cells and the virus is unable to bind..."